Cardiovascular disease (CVD) is the primary cause of death among adults over age 65 years. Seniors are also likely to have ...

Sponsor:  Consultancy Media for Sanofi and Regeneron In the state of Ohio alone, more than 800,000 people are living with COPD. It’s a chronic lung disease that limits air flow and ...

Vitamin D is essential for bone health, immune function and overall well-being. And it becomes even more crucial as we age.

The use of high-dose vitamin B12 in patients with septic shock may not be associated with a mortality benefit.

The surprise finding hints that anti–acid reflux therapy may provide benefit in COPD, possibly by reducing micro-aspirations, ...

Eating pumpkin every day can keep you regular, reduce inflammation, strengthen your immune system and help promote eye health ...

Trendy beetroot juice supplements lower blood pressure and improve ... that a 12-week course of a daily beetroot juice supplement for people with chronic obstructive pulmonary disease (COPD) reduced ...

N-acetylcysteine (NAC) nebulizer therapy is effective and safe in the short-term (12 weeks) for reducing phlegm in COPD.

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) as an add-on maintenance treatment for chronic obstructive pulmonary disease (COPD). The ...

Dupixent is now cleared for use as an add-on maintenance treatment for adults with a certain kind of chronic obstructive pulmonary disease, or COPD, that can’t be controlled with other medications.

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations ...

Over the last decade, as other companies—such as AstraZeneca with IL-5 inhibitor Fasenra—struggled to advance candidates for COPD, Regeneron and Sanofi took a more “phenotype-driven approach ...